Cargando…

Switching patients from other inhaled corticosteroid devices to the Easyhaler(®): historical, matched-cohort study of real-life asthma patients

PURPOSE: To investigate the clinical and cost effectiveness of switching real-life asthma patients from other types of inhalers to the Easyhaler(®) (EH) for the administration of inhaled corticosteroids (ICS). PATIENTS AND METHODS: Historical, matched-cohort study of 1,958 asthma patients (children...

Descripción completa

Detalles Bibliográficos
Autores principales:	Price, David, Thomas, Vicky, von Ziegenweidt, Julie, Gould, Shuna, Hutton, Catherine, King, Christine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2014
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3986277/ https://www.ncbi.nlm.nih.gov/pubmed/24748807 http://dx.doi.org/10.2147/JAA.S59386

Ejemplares similares

Inhaled corticosteroids for asthma: impact of practice level device switching on asthma control
por: Thomas, Mike, et al.
Publicado: (2009)

Switching to the Dry-Powder Inhaler Easyhaler(®): A Narrative Review of the Evidence
por: Lavorini, Federico, et al.
Publicado: (2021)

Inhaler Competence and Patient Satisfaction with Easyhaler(®): Results of Two Real-Life Multicentre Studies in Asthma and COPD
por: Gálffy, Gabriella, et al.
Publicado: (2013)

Easyhaler(®): an overview of an inhaler device for day-to-day use in patients with asthma and chronic obstructive pulmonary disease
por: Lavorini, Federico
Publicado: (2019)

Preference for Easyhaler(®) Over Previous Dry Powder Inhalers in Asthma Patients: Results of the DPI PREFER Observational Study
por: Alvarez-Gutiérrez, Francisco Javier, et al.
Publicado: (2021)

Today’s improvement in asthma treatment: role of MART and Easyhaler
por: Di Marco, Fabiano
Publicado: (2020)

Cost-effectiveness of initiating extrafine- or standard size-particle inhaled corticosteroid for asthma in two health-care systems: a retrospective matched cohort study
por: Martin, Richard J, et al.
Publicado: (2014)

Consistent Dosing Through the Salmeterol–Fluticasone Propionate Easyhaler for the Management of Asthma and Chronic Obstructive Pulmonary Disease: Robustness Analysis Across the Easyhaler Lifetime
por: Turpeinen, Anni, et al.
Publicado: (2021)

Cost-effectiveness analysis of corticosteroid inhaler devices in primary care asthma management: A real world observational study
por: Kemp, Linda, et al.
Publicado: (2010)

A non-interventional switch study in adult patients with asthma or COPD on clinical effectiveness of salmeterol/fluticasone Easyhaler(®) in routine clinical practice
por: Vinge, Ines, et al.
Publicado: (2021)

Inhaled Corticosteroids and Adult Asthma
por: Boulet, Louis-Philippe, et al.
Publicado: (2019)

Asthma-Related Outcomes in Patients Initiating Extrafine Ciclesonide or Fine-Particle Inhaled Corticosteroids
por: Postma, Dirkje S., et al.
Publicado: (2017)

Characteristics of reversible and nonreversible COPD and asthma and COPD overlap syndrome patients: an analysis of salbutamol Easyhaler data
por: Müller, Veronika, et al.
Publicado: (2016)

COVID-19, Asthma, and Inhaled Corticosteroids: Another Beneficial Effect of Inhaled Corticosteroids?
por: Maes, Tania, et al.
Publicado: (2020)

Effectiveness and Patient Satisfaction with Budesonide/Formoterol Easyhaler(®) Among Patients with Asthma or COPD Switching from Previous Treatment: a Real-World Study of Patient-Reported Outcomes
por: Gálffy, Gabriella, et al.
Publicado: (2019)

Long-acting muscarinic antagonist use in adults with asthma: real-life prescribing and outcomes of add-on therapy with tiotropium bromide
por: Price, David, et al.
Publicado: (2015)

Inhaled Corticosteroids in Asthma and the Risk of Pneumonia
por: Kim, Min-Hye, et al.
Publicado: (2019)

Asthma and Therapeutics: Inhaled Corticosteroids, Corticosteroid Osteoporosis, and the Risk of Fracture in Chronic Asthma
por: Toogood, John H
Publicado: (2005)

Characteristics and first treatment dose of Dutch patients (12-60 years old) receiving prescriptions for asthma and initiating inhaled corticosteroids (ICS) therapy as either extra-fine (EF) ciclesonide or standard-particle (SP)-ICS
por: Van Eickles, Daniela, et al.
Publicado: (2015)

An evaluation of exact matching and propensity score methods as applied in a comparative effectiveness study of inhaled corticosteroids in asthma
por: Burden, Anne, et al.
Publicado: (2017)

Inhaled corticosteroids may prevent lung cancer in asthma patients
por: Wang, I-Jen, et al.
Publicado: (2018)

Pharmacokinetics of Salmeterol and Fluticasone Propionate Delivered in Combination via Easyhaler and Diskus Dry Powder Inhalers in Healthy Subjects
por: Kirjavainen, Merja, et al.
Publicado: (2018)

Inhaled corticosteroids in childhood asthma: the story continues
por: van Aalderen, Wim M. C., et al.
Publicado: (2010)

Extrafine inhaled corticosteroid therapy in the control of asthma
por: Ivancsó, István, et al.
Publicado: (2013)

The use of inhaled corticosteroids in pediatric asthma: update
por: Hossny, Elham, et al.
Publicado: (2016)

Effect of inhaled corticosteroids on systemic inflammation in asthma
por: Karthikeyan, Ramaraju, et al.
Publicado: (2014)

Asthma progression and mortality: the role of inhaled corticosteroids
por: O'Byrne, Paul, et al.
Publicado: (2019)

Inhaled corticosteroids: not just for asthma, but for COVID-19?
por: Liew, Felicity, et al.
Publicado: (2022)

Inhaled Corticosteroids Is Not Associated with the Risk of Pneumonia in Asthma
por: Lee, Ye Jin, et al.
Publicado: (2023)

Effectiveness and Treatment Compliance of Salmeterol–Fluticasone Easyhaler(®) Among Patients with Asthma, COPD, or Asthma–COPD Overlap Syndrome: Real-World Study Findings
por: Tamási, Lilla, et al.
Publicado: (2022)

Comparing the effectiveness of small-particle versus large-particle inhaled corticosteroid in COPD
por: Postma, Dirkje S, et al.
Publicado: (2014)

Patients with asthma or chronic obstructive pulmonary disease (COPD) can generate sufficient inspiratory flows via Easyhaler(®) dry powder inhaler: a pooled analysis of two randomized controlled trials
por: Malmberg, L. Pekka, et al.
Publicado: (2021)

A Multicenter, Observational, Prospective Study of the Effectiveness of Switching from Budesonide/Formoterol Turbuhaler(®) to Budesonide/Formoterol Easyhaler(®)
por: Syk, Jörgen, et al.
Publicado: (2019)

Size of Inhaled Corticosteroid and Small Airway Inflammation in Asthma
por: Park, Choon-Sik
Publicado: (2017)

Inhaled Corticosteroids in Asthma: Promoting or Protecting Against Atherosclerosis?
por: Podgórski, Michał, et al.
Publicado: (2017)

Risk of Pneumonia Associated With the Use of Inhaled Corticosteroids in Asthma
por: Kim, Sang-Heon
Publicado: (2019)

Reply to Boulet and Nair: Inhaled Corticosteroids and Adult Asthma
por: Beasley, Richard, et al.
Publicado: (2019)

Asthma and treatment with inhaled corticosteroids: associations with hospitalisations with pneumonia
por: Ekbom, Emil, et al.
Publicado: (2019)

Pharmaco-Metabolomics of Inhaled Corticosteroid Response in Individuals with Asthma
por: Kachroo, Priyadarshini, et al.
Publicado: (2021)

Dynamics of inhaled corticosteroid use are associated with asthma attacks
por: Lee, Joy, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kj9ot4vsle09dn4hg6cpsl1j72